News

wvgazettemail.com6dOpinion
Eric Arnold: Look both ways before crossing out Medicaid (Opinion)
My favorite story as a 38-year-old man living with Spinal Muscular Atrophy Type II, a form of Muscular Dystrophy that renders ...
Sarepta Therapeutics Announces First Quarter 2025 Financial Results and Recent Corporate Developments
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...
European Medical Journal11d
Spotlight on Becker Muscular Dystrophy: Understanding the Lived Experience of Becker and Clinical Advancements with a Novel Agent
The symposium took place on 18 th March 2025, as part of the Muscular Dystrophy Association (MDA) Clinical & Scientific ...
The Associated Press on MSN11d
Chilean woman with muscular dystrophy becomes face of euthanasia debate as bill stalls in Senate
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Susana ...
News-Medical.Net on MSN13d
Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy
A new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...
Entrada Therapeutics Reports First Quarter 2025 Financial Results
Receives regulatory authorization in the EU for ELEVATE-44-201, a Phase 1/2 MAD clinical study of ENTR-601-44 in patients living with Duchenne muscular dystrophy who are amenable to exon 44 skipping – ...